Recently, China Life Investment Insurance Asset Management Co., Ltd. ("China Life Investment")'s subsidiary, China Life Jinshi Asset Management Co., Ltd., in partnership with relevant entities in Fujian Province, jointly initiated and established the "Fujian Xinrui Jieli Sci-Tech Innovation Fund." With a total fund size exceeding RMB 4 billion, it stands as one of the largest blind-pool S funds in China.
The fund primarily focuses on strategic emerging industries such as next-generation information technology, biomedicine and medical devices, and high-end equipment manufacturing. By participating in secondary market transactions of investment fund shares and facilitating the restructuring and continuation of funds, it provides long-term and stable capital support for tech-innovation enterprises, fully embodying its positioning of "relaying capital to sustain tech-innovation momentum."
Serving as the legal counsel to China Life Investment, Llinks leveraged its professional accumulation in insurance fund investment and financing as well as private equity funds to provide efficient, professional, and comprehensive legal support throughout the successful implementation of this project.
Llinks Engagement Team
Yi Wang, Partner
Wenjie Xing, Partner
Melissa Xu, Associate
Jiamei Wang, Associate
